$ZWS

Zurn Elkay Water Solutions Cor Q2 Earnings Call Highlights

Zurn Elkay Water Solutions (NYSE: ZWS) reported Q2 call highlights, including $48M cash from IEPA and reciprocal tariff refunds, with $60M remaining uncollected. Net debt leverage ended at 0.3x. It completed the $109M Intellihot acquisition, targeting $37M sales in 2026 and raised 2026 outlook: adj. EBITDA $503M-$513M and FCF at least $350M (excluding refunds).

Original reporting
Published Aug 1, 2026, 7:03 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 1, 2026, 6:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Zurn Elkay Water Solutions Cor Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$ZWSBullishMed
01

Why it matters

The key tradable update is the raised 2026 outlook (adjusted EBITDA and free cash flow) alongside specific Q3 and Q4 core sales growth and margin expectations, plus Intellihot’s economics and expected contribution window.

02

Market read

Traders can reprice ZWS on raised forward sales, margin, and cash-flow targets, with acquisition-driven growth assumptions and tariff transition included in management’s outlook.

03

What to watch

Intellihot is guided as not acquired for near-term earnings contribution, so investors may scrutinize execution risk versus the stated 5 to 6 year $100M, 30% EBITDA margin path.

Relevance 7/10Novelty 6/10Timing: post-Q2 earnings call, outlook raised for 2026

Background

The piece summarizes Zurn Elkay’s Q2 earnings call, including one-time IEPA/tariff refund accounting, acquisition of Intellihot, margin progress, and updated full-year outlook.

Company-level read

Ticker impact

$ZWSBullishMedium confidence
Context

Zurn Elkay raised full-year outlook and guided 2026 adjusted EBITDA $503M to $513M plus FCF at least $350M, excluding IEPA refunds.

Expected impact

Likely positive bias for the stock as raised outlook and Intellihot growth/margin targets improve forward earnings and FCF visibility.

Evidence & confidence

The article discloses specific updated 2026 targets, Q3/Q4 core sales growth ranges, and acquisition economics (sales, margins, and expected contribution), which are direct inputs to valuation and positioning.

Market effects

Commercial water-heating and filtration mix commentary may support sentiment toward efficiency-driven plumbing/water infrastructure demand.

No explicit regional demand or regulatory shock beyond tariff transition assumptions.

China sourcing reduction and tariff transition framing could influence broader industrial supply-chain risk perception.

Counterpoint

Guidance excludes IEPA reciprocal tariff refunds, so underlying cash generation may be less strong than headline FCF suggests.

Key entities

  • Zurn Elkay Water Solutions Corp

    NYSE-listed water delivery and plumbing products provider; raised 2026 outlook and discussed Intellihot acquisition economics and margin progress.

  • Intellihot

    Producer of commercial tankless condensing water heaters; acquisition price, 2026 sales/margins, and longer-term EBITDA margin targets were outlined.

Related articles

$ZWSMed

ZWS: Record Q2 growth and margins, boosted by Intellihot acquisition and raised full-year outlook

Zurn Elkay Water Solutions (ZWS) reported Q2 2026 results with 10% organic sales growth and record EBITDA margins, citing strength in Water Safety, Drinking Water, and Flow Systems. The company said its Intellihot acquisition expands its addressable market. ZWS also raised its full-year guidance for sales, EBITDA, and free cash flow, according to its Q2 2026 transcript.

$ZWSMedAI 8/10

Zurn Water: Q2 Earnings Snapshot

Zurn Water Solutions (ZWS) reported Q2 profit of $113.3 million, or 67 cents per share. Adjusted earnings were 50 cents per share versus a Zacks/Wall Street estimate of 47 cents. Revenue was $491 million, above the $482.4 million expected by analysts surveyed by Zacks.

$ZWSMedAI 8/10

Zurn Elkay (NYSE:ZWS) Posts Better

Zurn Elkay (NYSE:ZWS) reported Q2 CY2026 results. Revenue rose 10.5% year on year to $491 million and exceeded Wall Street estimates by 1.6%. Non-GAAP profit was $0.50 per share, 5.8% above consensus. The company said it is raising its full-year outlook and repurchased $50 million of shares in the quarter.

$ZWSMed

Zurn Elkay Water Solutions Corp (ZWS): Results of Operations and Financial Condition

Zurn Elkay Water Solutions Corp (ZWS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991earningsrelease63026.htm EX-99.1 Document Exhibit 99.1 Press Release July 28, 2026 Contact Information: For Immediate Release Bobbi Belstner Vice President, Corporate Controller 414.361.0122 Zurn Elkay Water Solutions Reports Second Quarter 2026 Financial Results I